| | 864821-90-9 Basic information More.. |
| Product Name: | Eluxadoline | | Synonyms: | JNJ 27018966;Eluxadoline;Benzoic acid, 5-[[[(2S)-2-amino-3-[4-(aminocarbonyl)-2,6-dimethylphenyl]-1-oxopropyl][(1S)-1-(5-phenyl-1H-imidazol-2-yl)ethyl]amino]methyl]-2-methoxy-;CS-2329;Eluxadoline (Viberzi);5-(((S)-2-amino-3-(4-carbamoyl-2,6-dimethylphenyl)-N-((S)-1-(4-phenyl-1H-imidazol-2-yl)ethyl)propanamido)methyl)-2-methoxybenzoic acid;Eluxadolin;API-Diarrhea | | CAS: | 864821-90-9 | | MF: | C32H35N5O5 | | MW: | 569.65 | | EINECS: | 1592732-453-0 | | Mol File: | 864821-90-9.mol |  |
Use
Eluxadoline is approved for the treatment of diarrhea-predominant irritable bowel syndrome (IBS-D). Eluxadoline, an orally dosed agent, employs a unique mechanism for IBS-D treatment, as it functions simultaneously as a μ- and κ-opioid receptor agonist and a δ- opioid receptor antagonist, leading to a first-in-class therapy for treatment of IBS-D.
- Eluxadoline
-
- US $0.00 / g
- 2026-04-30
- CAS:864821-90-9
- Min. Order: 1g
- Purity: More Than 99%
- Supply Ability: 100kg/Month
- Elu Xadoline
-
- US $0.00 / g
- 2026-04-30
- CAS:864821-90-9
- Min. Order: 1g
- Purity: More Than 99%
- Supply Ability: 100kg/Month
- Eluxadoline
-
- US $0.00-0.00 / KG
- 2020-07-22
- CAS:864821-90-9
- Min. Order: 1g
- Purity: 99%
- Supply Ability: 50kg/month
|
|
864821-90-9
Recommend Suppliers |
|